SIGN UP
LOG IN
MARKET
GYRE
GYRE
Gyre Therapeutics Inc
NASDAQ
17.68
+1.62
+10.09%
After Hours: 17.71 +0.03 +0.17% 17:37 12/05 EST
OPEN
18.00
PREV CLOSE
16.06
HIGH
19.43
LOW
17.40
VOLUME
162.37K
TURNOVER
0
52 WEEK HIGH
27.39
52 WEEK LOW
2.831
MARKET CAP
1.35B
P/E (TTM)
-0.8581
1D
5D
1M
3M
1Y
5Y
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Daktronics, inc. Shares fell 10.7% to $9.15 on tuesday. Daktronics posted weak quarterly results. Meiwu technology company limited shares climbed 80.6% in the mid-day session. Volato group, inc., volato, and nxu were among the top gainers.
Benzinga · 1d ago
NIO Reports Q3 Results, Joins Hovnanian Enterprises, Signet Jewelers And Other Big Stocks Moving Higher On Tuesday
Dow jones index falls more than 100 points on tuesday. Shares of nio inc. Moved higher after the company reported third-quarter financial results and issued guidance. Xbp europe holdings, inc. Shares gained 24.7% to $47.40. Nio reported revenue of $2.61 billion in the third quarter.
Benzinga · 1d ago
Travere Therapeutics, Replimune among healthcare movers
Clearmind medicine, travere therapeutics, replimune among healthcare movers. S&p 500 health care sector down 0.66% to 1525.57. Health care equipment & services contributes 0.61% to the index's losses. Clearmind and travere among the top gainers in the sector.
Seeking Alpha · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Allarity therapeutics shares rose 44.0% to $0.86 during tuesday's pre-market session. Sonoma pharmaceuticals stock rose 26.15% and onemednet stock moved upwards by 23.54%. Losers replimune group (nasdaq:repl) and ibio (amex:ibio) stock fell.
Benzinga · 1d ago
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Volato stock is rocketing 480% after completing a special purpose acquisition company merger. Meiwu technology shares are soaring more than 136% ahead of its delisting notice. The biggest pre-market stock movers are a spac merger, delisting notices, earnings reports and more.
Investorplace · 1d ago
Weekly Report: what happened at GYRE last week (1127-1201)?
Weekly Report · 2d ago
Catalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility redux
Short interest levels pushed higher on faraday future intelligent electric and fisker. Options trading volume spiked on gamestop ahead of the retailer's earnings report. October factory orders report will be released on december 4. Notable investor events scheduled for next week include mcdonald's event, lululemon earnings.
Seeking Alpha · 5d ago
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Titan machinery shares declined 8.1% to $23.41 on thursday. Minim inc shares jumped 700% after gaining over 13% on wednesday. Salesforce shares gained 8.4% after reporting strong third-quarter results. Redhill biopharma ltd. Shares fell 31% after the company reported weak quarterly results.
Benzinga · 6d ago
About GYRE
Gyre Therapeutics, Inc., formerly Catalyst Biosciences, Inc., is a biotechnology company. The Company is focused on organ fibrosis and inflammatory diseases. The Company is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). The Company is also advancing a diverse pipeline in China through a controlling interest in Beijing Continent, including pirfenidone, F573, F528, and F230. Pirfenidone is used for idiopathic pulmonary fibrosis and is undergoing Phase 3 trials in dermatomyositis interstitial lung disease, systemic sclerosis-associated interstitial lung disease, and pneumoconiosis, along with a Phase 1 trial in diabetic kidney disease. F573 is being investigated for acute-on-chronic liver failure, while F528 and F230 are being evaluated for chronic obstructive pulmonary disease and pulmonary arterial hypertension, respectively.
Webull offers Gyre Therapeutics Inc stock information, including NASDAQ: GYRE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GYRE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.
You can practice and explore trading GYRE stock methods without spending real money on the virtual paper trading platform.